These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Vaginal estrogen creams: use patterns among a cohort of women. Keenan NL; Franks AL; Croft JB; Scholes D; Murray ET J Am Geriatr Soc; 1999 Jan; 47(1):65-70. PubMed ID: 9920231 [TBL] [Abstract][Full Text] [Related]
43. Vaginal estrogen therapy for the treatment of atrophic vaginitis. Lynch C J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364 [TBL] [Abstract][Full Text] [Related]
44. [Estrogen treatment only when symptoms are present but complaints should not be neglected]. Widholm O Nord Med; 1977 May; 92(5):153. PubMed ID: 866107 [TBL] [Abstract][Full Text] [Related]
45. Estrogen therapy: the dangerous road to Shangri-La. Consum Rep; 1976 Nov; 41(11):642-5. PubMed ID: 1028554 [TBL] [Abstract][Full Text] [Related]
46. Community surveillance bias and the estrogen-endometrial cancer dispute. Horwitz RI; Feinstein AR CA Cancer J Clin; 1979; 29(4):252-6. PubMed ID: 110409 [TBL] [Abstract][Full Text] [Related]
47. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. North American Menopause Society Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512 [TBL] [Abstract][Full Text] [Related]
48. Estrogen replacement therapy: current thinking and practice. DeFazio J; Speroff L Geriatrics; 1985 Nov; 40(11):32-7, 40-3, 47-8. PubMed ID: 4054632 [TBL] [Abstract][Full Text] [Related]
49. Cancer and the use of estrogens. Gambrell RD Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032 [TBL] [Abstract][Full Text] [Related]
50. [Estrogen and endometrial carcinoma]. Lauritzen C MMW Munch Med Wochenschr; 1979 Apr; 121(15):499. PubMed ID: 108554 [No Abstract] [Full Text] [Related]
51. Postpartum vaginal agglutination: a case report. Howard TF; Lewicky-Gaupp C Female Pelvic Med Reconstr Surg; 2012; 18(3):188-9. PubMed ID: 22543776 [TBL] [Abstract][Full Text] [Related]
52. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006 [TBL] [Abstract][Full Text] [Related]
53. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy. Simon JA; Maamari RV Climacteric; 2013 Aug; 16 Suppl 1():37-43. PubMed ID: 23848490 [TBL] [Abstract][Full Text] [Related]
54. Necropsy diagnosis of endometrial cancer and detection-bias in case/control studies. Horwitz RI; Feinstein AR; Horwitz SM; Robboy SJ Lancet; 1981 Jul; 2(8237):66-8. PubMed ID: 6113441 [TBL] [Abstract][Full Text] [Related]
55. Methodological issues in epidemiologic studies of endometrial cancer and exogenous estrogen. Hulka BS; Hogue CJ; Greenberg BG Am J Epidemiol; 1978 Apr; 107(4):267-76. PubMed ID: 645695 [TBL] [Abstract][Full Text] [Related]